Home
>
National Drug Code (NDC)
>
Primaquine Phosphate
Primaquine Phosphate - 43063-225-14 - (Primaquine Phosphate)
Drug Information of Primaquine Phosphate
| Product NDC: | 43063-225 |
| Proprietary Name: | Primaquine Phosphate |
| Non Proprietary Name: | Primaquine Phosphate |
| Active Ingredient(s): | 26.3 mg/1 & nbsp; Primaquine Phosphate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Primaquine Phosphate
| Product NDC: | 43063-225 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA008316 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100101 |
Package Information of Primaquine Phosphate
| Package NDC: | 43063-225-14 |
| Package Description: | 14 TABLET in 1 BOTTLE, PLASTIC (43063-225-14) |
NDC Information of Primaquine Phosphate
| NDC Code | 43063-225-14 |
| Proprietary Name | Primaquine Phosphate |
| Package Description | 14 TABLET in 1 BOTTLE, PLASTIC (43063-225-14) |
| Product NDC | 43063-225 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Primaquine Phosphate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100101 |
| Marketing Category Name | ANDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | PRIMAQUINE PHOSPHATE |
| Strength Number | 26.3 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antimalarial [EPC] |
